Memorial MedSpa is excited to announce the addition of Jennifer Myers, APRN, FNP-C, to its team of expert providers. With a ...

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

Mereo BioPharma shifts focus to rare diseases with setrusumab showing strong results for Osteogenesis Imperfecta. Learn more on MREO stock here.

New research provides further evidence that thrombolysis benefits select patients with acute ischemic stroke up to 24 hours after symptom onset.

AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...

Celebrities and wellness influencers are getting routine NAD+ infusions as an anti-aging hack, but are these expensives IV ...

Welcome to SHA Wellness, a new-age clinic with locations in Spain, Mexico, and the UAE, that mixes science with the holistic ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Mechanically retrieving a blood clot blocking a medium- or small-sized brain artery was no better at reducing disability 90 days after a stroke than standard care alone (including clot-busting ...

The owners and staff of Woodstock Infusions (L-R): manager Tania Cawthron, owner and registered nurse Kim Rice, founder and owner Marc Baumslag and registered nurse Anna Schlosser. (Photos by Lauren ...

Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment for a common type of stroke; however, it did not lessen disability more than best medical ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...